Lantern Pharma Inc. (LTRN)
Lantern Pharma Announces Public Release of Transformative, Advanced AI Module for Blood-Brain Barrier Permeability Prediction, predictBBB.ai™
BioVie Inc. (BIVI)
Praxis Precisions Medicines Inc (PRAX)
NeuroBo Pharmaceuticals Inc. (NRBO)
Anixa Biosciences Inc. (ANIX)
Anixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming Phase 2 Breast Cancer Vaccine Trial
Capricor Therapeutics Inc. (CAPR)
The Gross Law Firm Notifies Capricor Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - CAPR
Sonnet BioTherapeutics Holdings Inc. (SONN)
Sonnet BioTherapeutics Expands Clinical Evaluation of SON-1010 Dose Escalation with Atezolizumab in Ovarian Cancer
Genprex Inc. (GNPX)
Genprex Issues Stockholder Letter and Provides 2025 Corporate Update
Genprex Inc. (GNPX)
Genprex Inc. (GNPX)
Equillium Inc. (EQ)
New Form 8-K - Equillium, Inc. Filed: 2025-08-04 AccNo: 0001193125-25-172207 Size: 530 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Heart Test Laboratories Inc (HSCSW)
Praxis Precisions Medicines Inc (PRAX)
Vor Biopharma Inc (VOR)
Vor Bio Appoints Seasoned Biotech Executive Dallan Murray as Chief Commercial Officer
Star Equity Holdings Inc. (STRRP)
Star Equity Holdings to Release Second Quarter 2025 Financial Results on August 13